期刊文献+

肿瘤患者血清线粒体肌酸激酶水平变化及其诊断意义研究进展 被引量:4

Serum mitochondrial creatine kinase levels in the diagnosis of patients with malignant tumor
下载PDF
导出
摘要 线粒体肌酸激酶(Mt CK)存在于细胞内线粒体内膜和外膜间隙,属肌酸激酶同工酶系列,其主要生理作用是在有氧情况下通过磷酸肌酸穿梭机制提供肌肉收缩所需能量。近年来,很多研究发现Mt CK在肿瘤患者血清中高表达,且大多数是患有恶性肿瘤患者的血清中Mt CK呈高表达,在预后不好的病人中过表达尤其明显,推测其对恶性肿瘤的临床诊断及预后判断具有重要意义。同时,分子生物学研究认为Mt CK过表达可以使细胞在某种程度上获得一定的生长优势以抵抗调亡。 Mitochondrial creatine kinase (MtCK) located in the space between inner membrance and outer membrance of intraeenular mitochondria. Creatine kinase is a member of the creatine kinase isozyme. The mainly physiological function of MtCK is to provide the energy for muscle contraction through the creatine phosphate shuttle mechanism under aerobic condition, which plays an important role in mitochondrial respiratory control. Recently,over expression of ubiquitous MtCK (uMtCK) is found in malignant tumors with especially poor prognosis. The molecular biology mechanism of the over expression in malignant tumors is well studied and the scholars find that uMtCK might be useful in the diagnosis of malignant tumors. Meanwhile,molecular biology studies shows that over expression of uMtCK promotes malignant tumors growth though resisting apoptosis. We reviewed the role and molecular biologic mechanism of mitochondrial creatine kinase in the diagnosis of malignant tumor.
作者 张宁宁 陆伟
出处 《实用肝脏病杂志》 CAS 2015年第4期445-448,共4页 Journal of Practical Hepatology
基金 天津市卫生局科技基金面上项目(编号:2013KY01)
关键词 肿瘤 线粒体肌酸激酶 临床诊断 Nooplasma Mitochondrial creatine kinase Clinical diagnosis
  • 相关文献

参考文献7

二级参考文献75

  • 1李涤臣.肺癌的病理诊断[J].临床与实验病理学杂志,1994,10(3):255-257. 被引量:5
  • 2邓永江,丁华野,吴霞,周旭东,皋岚湘,张英,周景,杨德忠.肺癌组织铜锌超氧化物歧化酶免疫组化的研究[J].临床与实验病理学杂志,1994,10(3):190-192. 被引量:2
  • 3Heather HARTIG,Ivan DZHAGALOV,David DRAPER.The role of apoptosis in the development and function of T lymphocytes[J].Cell Research,2005,15(10):749-769. 被引量:16
  • 4Martin K J, Chen SF, Clark GM, et al. Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells [J]. J Natl Cancer Inst, 1994, 86:608-613.
  • 5Pratt R, Vallis LM, Lim CW, et al. Mitochondrial creatine kinase in cancer patients [J]. Pathology,1987,19:162-165.
  • 6Kanemitsu F, Kawanishi I, Mizushima J, et al. Mitochondrial creatine kinase as a tumor-associated marker [J]. Clin Chim Acta, 1984,138 : 175-183.
  • 7Wyss M, Smeitink J, Wevers RA, et al. Mitochondrial creatine kinase:a key enzyme of aerobic energy metabolism[J]. Biochim Biophys Acta, 1992, 1102:119-166.
  • 8Crompto M. The mitochondrial permeability transition pore and its role in cell death[J]. Biochem J, 1999,341 : 233-249.
  • 9Sehiemann S, Sehwirzke M, Brunner N, et al. Molecular analysis of two mammary carcinoma cell lines at the transcriptionallevel as a model system for progression of breast cancer [J]. Clin Exp Metastasis,1998,16 : 129-139.
  • 10Kornacker M, Schlattner U, Wallimann T, et al.Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis[J]. Int J Cancer, 2001, 94:513-519.

共引文献31

同被引文献20

引证文献4

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部